Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FX04J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,800
Award facts
- Contract value 100% obligated
- $12,800.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12.8K on June 18, 2025, for RINVOQ ER 15 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing a specialty pharmaceutical product commonly procured through federal medical supply channels.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999B and extending through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp regularly fulfills federal medical procurement requirements through open competition. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FX04J?
SPE2DB25FX04J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FX04J worth?
The government has obligated $12,800 on SPE2DB25FX04J.
Is contract SPE2DB25FX04J an order under another contract?
Yes. SPE2DB25FX04J is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX04J competed?
The extent of competition for SPE2DB25FX04J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award